Ranking Profile - Alteogen Inc
Introduction
Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-Q5, ALT-P7, ALT-L9, ALT-LS2 and ALT-L2. Alteogen also develops NexP Fusion technology and NexMab ADC technology. The company’s NexP Fusion technology is a second-generation long-acting technology that uses DNA recombination and human A1AT (alpha-1 antitrypsin) protein in human blood as the protein carrier and its NexMab ADC Technology develops anti-cancer drugs which selectively track and removes cancer cells while it does not affect healthy cells. It operates its office in Seoul, South Korea. Alteogen is headquartered in Daejeon, South Korea.
Company info
Country (HQ): | South Korea |
Sector: | Pharmaceuticals and Healthcare |
Market Cap (US$ m): | 1,808 |
Revenue (US$ m): | 22 (2022) |
Innovation ranking
Innovation score
Closest peers in the Pharmaceuticals and Healthcare sector
Innovation Ranking
Johnson & Johnson
United States
Pharmaceuticals and Healthcare
F. Hoffmann-La Roche Ltd
Switzerland
Pharmaceuticals and Healthcare
Alteogen Inc
South Korea
Pharmaceuticals and Healthcare
EyeGate Pharmaceuticals Inc
United States
Pharmaceuticals and Healthcare
Shin Poong Pharm Co Ltd
South Korea
Pharmaceuticals and Healthcare
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release